Bryn Mawr Trust CO Moderna, Inc. Transaction History
Bryn Mawr Trust CO
- $5.88 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Moderna, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 1,095 shares of MRNA stock, worth $29,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,095
Previous 2,649
58.66%
Holding current value
$29,740
Previous $73,000
61.64%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
857Shares Held
266MCall Options Held
28.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$694 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$593 Million0.44% of portfolio
-
State Street Corp Boston, MA17.3MShares$469 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$241 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...